Skip to content
TechVibe

TechVibe

  • Home
  • Web3
  • Technology
  • Health
  • Business
  • Sports
    • Cricket
    • Football
  • Press Release
  • Contact Us
  • Toggle search form

Rephrase the title:Entero Healthcare Solutions IPO fully subscribed on final day despite muted NII participation

Posted on February 13, 2024February 17, 2026 By Robert Long

Rephrase and rearrange the whole content into a news article. I want you to respond only in language English. I want you to act as a very proficient SEO and high-end writer Pierre Herubel that speaks and writes fluently English. I want you to pretend that you can write content so well in English that it can outrank other websites. Make sure there is zero plagiarism.:

  • The initial public offering (IPO) of Entero Healthcare Solutions was fully subscribed on day three.
  • The company had fixed a lot size of 11 shares, allowing investors to bid for a minimum of 11 shares and in multiples thereof.
  • The company had fixed the price band at ₹1,195 to ₹1,258 per equity share.

After a muted start, the initial public offering (IPO) of Entero Healthcare Solutions Limited has finally been fully subscribed on day three. The Entero Healthcare Solutions had received only 9% subscription on its first day.

While the IPO was fully subscribed, non-institutional investors (NIIs) did not fully subscribe to the shares reserved for them. Qualified institutional buyers (QIBs) stepped in on the final day to subscribe to the IPO.

The company had fixed the price band at ₹1,195 to ₹1,258 per equity share for its public offer which closed on Tuesday, February 13. The minimum bid quantity was set at 38 equity shares and in multiples of 38 equity shares thereafter.

While the total issue size is ₹1,600 crore, it includes a fresh issue of shares worth ₹1,000 crore and an offer for sale (OFS) of shares worth ₹600 crore.

Ahead of the IPO, the company raised ₹716.4 crore from anchor investors.

Of the total IPO size, 75% was reserved for QIBs, 15% for NIIs and 10% for retail individual investors.

The company had reserved shares worth ₹8 crore for employees. Additionally, a discount of ₹119 per equity share was offered to eligible employees.

Entero Healthcare Solutions IPO subscription status

Category No. of times subscribed
Qualified Institutional Buyers 2.28
Non-institutional Investors 0.22
Retail 1.31
Employees 1.23
Total 1.53

Entero Healthcare Solutions, which was incorporated in 2018 is a distributor of healthcare products in India. It uses a technology-driven platform to facilitate distribution of healthcare products to hospitals, clinics and pharmacies across the country.

The company has relations with over 1,900 healthcare manufacturers across the country and caters to 3,400 hospitals and 81,400 pharmacies in 495 districts in the country as on March 31, 2023.

The company has 77 distribution warehouses across 38 cities.

SEE ALSO:

Using AI to impress someone this Valentine’s? Nearly 50% say they will be offended

Five out of the top-10 unlisted companies in India slipped in valuation in 2023

Apple domination: Seven out of top 10 smartphones sold worldwide are iPhones

Business Tags:entero healthcare solutions, Entero Healthcare Solutions ipo, Entero Healthcare Solutions ipo gmp, Entero Healthcare Solutions ipo subscription, ipo, ipo gmp, ipo subscription

Post navigation

Previous Post: Rephrase the title:RCB’s Reece Topley ruled out of IPL with injury – Who will replace the English pacer?
Next Post: Rephrase the title:What time is Man City vs FC Copenhagen? Live stream, TV channel, kickoff start for Champions League match

Related Posts

Cashify’s revenue increases by 64%, while losses soar by almost 50% to Rs 148 crore in FY23. Business
Rephrase the title:A ‘thaw in startup funding winter’ as two unicorns emerge within a quarter Business
Rephrase the title:Fiscal deficit target of 5.1% ambitious but achievable: Finance Secretary Business
Rephrase the title:Climate change could cause millions of children to be born prematurely, suffer lifelong complications Business
Rephrase the title:This 400-million-year-old fossil is the oldest disease-causing fungus we’ve ever seen! Business
Rephrase the title:A Japanese Start-Up Is Testing a Rocket Powered Entirely By Rocket Fuel Created From Cow Dung! Business

Recent Posts

  • In Studio, Not On Stage: When Shift Happens’ Kevin Follonier on Why He Never Networks
  • Prescribing Change: How a Doctor Turned Builder Is Decentralizing EV Charging With DCharge Network
  • From Forex Trader to Web3 Growth Architect: Spout Finance’s Onuro Gabriel on Building Trust in a Trust-Starved Industry
  • Aivora’s Voucher Alpha: The New Trading Rewards System is Here
  • Aivora Launches Unique Application Features: Voucher & VIP Zone

Categories

  • Business
  • Cricket
  • Football
  • Health
  • Interview
  • Press Release
  • Technology
  • Uncategorized
  • Web3

About Us

Welcome to TechVibe9, where the rhythm of technology meets innovation! We are a group of tech enthusiasts on a mission to uncover and showcase the latest in the tech world.

Mail Us : support@techvibe9.com

Latest Post

  • In Studio, Not On Stage: When Shift Happens’ Kevin Follonier on Why He Never Networks
  • Prescribing Change: How a Doctor Turned Builder Is Decentralizing EV Charging With DCharge Network
  • From Forex Trader to Web3 Growth Architect: Spout Finance’s Onuro Gabriel on Building Trust in a Trust-Starved Industry

Helpful Links

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions

Copyright © TechVibe9

Powered by PressBook Masonry Dark